Merck & Co., Inc. (NYSE: MRK) is listed among the 13 Best High Dividend Stocks to Buy Under $100, rewarding shareholders for the past 16 years with a dividend yield of 3.97%. Despite concerns about patent expiration and key drug revenue, MRK’s strong R&D capabilities and scale have helped maintain a steady track record.

The pharmaceutical giant, Merck & Co., Inc. (NYSE: MRK), faces challenges in drug discovery and patent expiry. However, its research strength, acquisition capacity, and track record of dividend growth make it a solid investment. While AI stocks may offer greater potential, MRK remains a reliable choice for long-term investors.

Investors have been drawn to Merck & Co., Inc. (NYSE: MRK) for its consistent dividend growth over the years. With a quarterly dividend of $0.81 per share and a yield of 3.97%, MRK is a top choice for those seeking reliable dividend stocks under $100. Despite potential risks, MRK’s track record speaks for itself.

For those seeking undervalued AI stocks, Merck & Co., Inc. (NYSE: MRK) offers stability but may not provide the same upside potential as other options. While MRK’s dividend history is strong, considering other investment opportunities in the AI sector may yield higher returns in the long run.

Read more at Yahoo Finance: Merck & Co (MRK) Among Top Dividend Stocks to Buy Under $100